1. 1069. Psychometric Properties of the Symptoms of Infection with Coronavirus-19: A Patient-Reported Outcome Measure for COVID-19 Signs and Symptoms. (15th December 2022) Authors: Chan, Eric K H; Stoddard, Jeffrey; Sadoff, Jerald; Liu, Yan; van Dromme, Ilse; Katz, Eva G; Liu, Yi-hsuan; McQuarrie, Kelly Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1522. Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model. (31st December 2020) Authors: Han, Alison; Czajkowski, Lindsay; Rosas, Luz Angela; Cervantes-Medina, Adriana; Xiao, Yongli; Gouzoulis, Monica; Lumbard, Keith; Hunsberger, Sally; Reed, Susan; Athota, Rani; Baus, Holly; Lwin, Amy; Sadoff, Jerald; Taubenberger, Jeffery; Memoli, Matthew J Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level. (15th December 2022) Authors: Comeaux, Christy A; Falsey, Ann R; Williams, Kristi; Bart, Stephan; Ervin, John E; Bastian, Arangassery R; Menten, Joris; De Paepe, Els; Vandenberghe, Sjouke; Chan, Eric K H; Sadoff, Jerald; Douoguih, Macaya; Callendret, Benoit; Heijnen, Esther Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Downward Trend of the Ratio of Influenza RNA Copy Number to Infectious Viral Titer in Hospitalized Influenza A-Infected Patients. (3rd November 2015) Authors: Van Wesenbeeck, Liesbeth; D'Haese, David; Tolboom, Jeroen; Meeuws, Hanne; Dwyer, Dominic E.; Holmes, Mark; Ison, Michael G.; Katz, Kevin; McGeer, Allison; Sadoff, Jerald; Weverling, Gerrit Jan; Stuyver, Lieven Journal: Open forum infectious diseases Issue: Volume 2:Number 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON®-TB Gold (+) Kenyan adults without evidence of tuberculosis. Issue 21 (5th May 2016) Authors: Walsh, Douglas S.; Owira, Victorine; Polhemus, Mark; Otieno, Lucas; Andagalu, Ben; Ogutu, Bernhards; Waitumbi, John; Hawkridge, Anthony; Shepherd, Barbara; Pau, Maria Grazia; Sadoff, Jerald; Douoguih, Macaya; McClain, J. Bruce Journal: Vaccine Issue: Volume 34:Issue 21(2016) Page Start: 2430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials. Issue 32 (30th July 2022) Authors: Sadoff, Jerald; Le Gars, Mathieu; Brandenburg, Boerries; Cárdenas, Vicky; Shukarev, Georgi; Vaissiere, Nathalie; Heerwegh, Dirk; Truyers, Carla; de Groot, Anne Marit; Jongeneelen, Mandy; Kaszas, Krisztian; Tolboom, Jeroen; Scheper, Gert; Hendriks, Jenny; Ruiz-Guiñazú, Javier; Struyf, Frank; Van H... Journal: Vaccine Issue: Volume 40:Issue 32(2022) Page Start: 4403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial. (13th November 2008) Authors: Hawkridge, Anthony; Hatherill, Mark; Little, Francesca; Goetz, Margaret Ann; Barker, Lew; Mahomed, Hassan; Sadoff, Jerald; Hanekom, Willem; Geiter, Larry; Hussey, Greg Journal: BMJ Issue: Volume 337(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022) Authors: Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). Issue 10143 (21st July 2018) Authors: Barouch, Dan H; Tomaka, Frank L; Wegmann, Frank; Stieh, Daniel J; Alter, Galit; Robb, Merlin L; Michael, Nelson L; Peter, Lauren; Nkolola, Joseph P; Borducchi, Erica N; Chandrashekar, Abishek; Jetton, David; Stephenson, Kathryn E; Li, Wenjun; Korber, Bette; Tomaras, Georgia D; Montefiori, David C... Journal: Lancet Issue: Volume 392:Issue 10143(2018) Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector–based COVID‐19 vaccine. Issue 1 (11th June 2022) Authors: Le Gars, Mathieu; Hendriks, Jenny; Sadoff, Jerald; Ryser, Martin; Struyf, Frank; Douoguih, Macaya; Schuitemaker, Hanneke Journal: Immunological reviews Issue: Volume 310:Issue 1(2022) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗